Prosecution Insights
Last updated: October 26, 2026

Erinne R Dabkowski, USPTO Patent Examiner

Listed by the USPTO as DABKOWSKI, ERINNE R

Tech Center 1600 • Art Units: 1654 1675 1683

This examiner grants 56% of resolved cases

Analysis

DABKOWSKI, ERINNE R is assigned to Tech Center 1600 and art unit 1654. The profile includes 719 resolved cases, an allowance rate of 55.8%, and a median of 1059 days to allowance. The interview lift is 68.7%, making examiner interviews a particularly prominent consideration in prosecution planning.

The listed companies are The Regents of the University of Michigan, Nestlé S.A., and The Chinese University of Hong Kong. The listed firms are Casimir Jones, S.C., WC&F IP, and K&L Gates LLP-Nestec S.A. The allowance history indicates that applicants may need sustained claim and argument development, while the interview measure supports direct examiner engagement as part of that effort.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

55.8%
Allow Rate
-4.2% vs TC avg
794
Total Applications
+68.7%
Interview Lift
1059
Avg Prosecution Days
Based on 719 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
14.7%
§102 Novelty
29.5%
§103 Obviousness
32.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18313856 COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS Final Rejection The Regents of the University of Michigan
18163773 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
17266897 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS Final Rejection THE REGENTS OF THE UNIVERSITY OF MICHIGAN
18199523 COMPOSITIONS AND METHODS USING A COMBINATION OF AUTOPHAGY INDUCER AND HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
17925455 Methods and Compositions for Treatment of Age-Related Dysfunction Non-Final OA The University of Tokyo
18007323 NUTRITION FORMULATION Final Rejection OTSUKA PHARMACEUTICAL FACTORY, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Erinne R Dabkowski's allowance rate?

55.8% of resolved applications examined by Erinne R Dabkowski were allowed (719 resolved cases), compared with 48.5% across Art Unit 1654 over the last five years.

Does an interview help with examiner Erinne R Dabkowski?

This examiner's interview lift is +68.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Erinne R Dabkowski take to allow a patent?

Applications allowed by Erinne R Dabkowski took 1,059 days on average from filing to allowance.

Which art unit does examiner Erinne R Dabkowski work in?

Erinne R Dabkowski examines applications in Art Unit 1654 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month